$PACS

Jergensen Joshua sold $1.8M of PACS

Jergensen Joshua (President & COO) sold 40,000 shares of PACS Group, Inc. (PACS) at an average of $45.59 ($44.53–$45.70, $1.82M total) across 2 trades on 2026-08-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Jergensen Joshua
Published Aug 14, 2026, 9:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 9:42 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PACS
Neutral
medium confidence
Mentioned
$PACS
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PACSNeutralLow
01

Why it matters

Traders may monitor insider activity as a sentiment input, but 10b5-1 sales are generally less informative than unscheduled sales.

02

Market read

A $1.82M insider sale by a top executive at PACS was newly disclosed, but the 10b5-1 structure suggests limited fundamental signal.

03

What to watch

The filing does not disclose reasons for the sale, and the net holdings after the sale remain large, limiting inference about long-term conviction.

Relevance 5/10Novelty 5/10Timing: Filed after-hours on 2026-08-14, reflecting sales executed on 2026-08-12.

Background

This is an SEC Form 4 insider transaction disclosure for PACS Group, Inc., reported by an officer (President and COO).

Company-level read

Ticker impact

$PACSNeutralMedium confidence
Context

PACS Group disclosed an insider open-market sale by President and COO Joshua Jergensen totaling about $1.82M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move solely from this Form 4; any impact is likely short-lived and sentiment-driven.

Evidence & confidence

The transaction is an open-market sale executed under a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.

Market effects

No clear sector read-through from a single insider sale at PACS.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • PACS Group, Inc.

    Company whose insider transaction was disclosed on SEC Form 4.

  • Joshua Jergensen

    President and COO who sold shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PACSHighAI 8/10

Why is PACS stock rallying today?

PACS stock rose 3.3% premarket after announcing two growth initiatives: acquiring 32 Florida nursing facilities and closing 11 more from the Eduro Healthcare deal, expanding its network to 355 buildings. The company's stock has recovered from a 52-week low of $7.50, now trading at $43.52. PACS's low leverage and favorable Medicare reimbursements support its growth strategy.

$PACSMed

PACS Group stock rises on Florida expansion, Eduro closings

PACS Group (NYSE:PACS) shares rose 3.3% premarket after announcing plans to acquire 32 Florida skilled nursing facilities, adding 4,049 beds. The deal, expected to close Q4, expands PACS's southern footprint. Additionally, PACS completed closings on 11 more Eduro Healthcare facilities, bringing total Eduro closings to 31 of 34. The company now operates 355 facilities across 7 states. CEO Jason Murray highlighted Florida's growth potential.

$PACSHigh

PACS Group, Inc. (PACS): Results of Operations and Financial Condition

PACS Group, Inc. (PACS) filed an SEC Form 8-K — Results of Operations and Financial Condition. PACS Group, Inc. Reports Second Quarter 2026 Results Conference Call and Webcast Scheduled for Tomorrow, August 5, 2026, at 11:30 am ET. SALT LAKE CITY, Utah, August 4, 2026 – PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of

$PACSMedAI 8/10

Shearwater Group Contract Extension Worth £25m Lifts AIM Shares 17.6%

Shearwater Group said it secured a five-year £25m contract extension with a UK telecoms client, covering packet monitoring and forensic services. £12.5m is to be recognised in 2025-26, but cash is expected after year end; net cash is forecast at £5.6m and pre-tax profit at £1.1m. Shares rose 17.6% to 43.5p. Polar Capital and Supreme also moved on results.